0001209191-16-130107.txt : 20160629 0001209191-16-130107.hdr.sgml : 20160629 20160629172735 ACCESSION NUMBER: 0001209191-16-130107 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160627 FILED AS OF DATE: 20160629 DATE AS OF CHANGE: 20160629 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001178711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330960223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 PARK PLAZA STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (617) 807-6600 MAIL ADDRESS: STREET 1: 75 PARK PLAZA STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc DATE OF NAME CHANGE: 20090130 FORMER COMPANY: FORMER CONFORMED NAME: NOVACEA INC DATE OF NAME CHANGE: 20020724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lim Richard J. CENTRAL INDEX KEY: 0001623720 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36066 FILM NUMBER: 161739786 MAIL ADDRESS: STREET 1: 185 DARTMOUTH STREET CITY: BOSTON STATE: MA ZIP: 02116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-27 0 0001178711 Paratek Pharmaceuticals, Inc. PRTK 0001623720 Lim Richard J. C/O PARATEK PHARMACUTICALS, INC. 75 KNEELAND STREET BOSTON MA 02111 1 0 0 0 Common Stock 2016-06-27 4 P 0 384615 13.00 A 779802 I By Omega Fund IV, L.P. Common Stock 2016-06-27 4 P 0 76923 13.00 A 1187365 I By Omega Fund III, L.P. These securities are held in the name of Omega Fund IV, L.P. ("Omega IV"). The Reporting Person is a director of Omega Fund IV GP Manager, Ltd., the general partner of Omega Fund IV GP, L.P., which is the general partner of Omega IV, and has shared voting and investment power over, and a proportionate pecuniary interest in, the shares held by Omega IV. The Reporting Person disclaims beneficial ownership of the securities held by Omega IV except to the extent of his proportionate pecuniary interest therein. These securities are held in the name of Omega Fund III, LP. ("Omega III"). Omega Fund III GP, L.P. ("Omega III GP LP") is the general partner of Omega III. Omega Fund III G.P., Ltd. ("Omega III GP") is the general partner of Omega III GP LP. Clessidra, LLC ("Clessidra") is the sole shareholder of Omega III GP. Omega III, Omega III GP LP, Omega III GP, Clessidra, Danish BV and Danish BV GP are collectively referred to as the "Omega Funds". As a result of an understanding relating to the Omega Funds, the Reporting Person may have an indirect pecuniary interest in the securities held by Omega III. The Reporting Person disclaims beneficial ownership of the securities held by Omega III except to the extent of his pecuniary interest therein. /s/ Richard J. Lim 2016-06-29